Amicus, Shire Team on Rare Gene R&D (TheStreet.com)
They will jointly develop lead compounds for three disorders: Fabry, Gaucher and Pompe.

House Subcommittee Chair Seeks Delay Of FDA Foundation Launch (Medical News Today)
House Appropriations Subcommittee on Agriculture Chair Rosa DeLauro (D-Conn.) on Thursday in a letter asked FDA officials to delay the launch of the Reagan-Udall Foundation because of concerns about the relationship between the foundation and industries regulated by the agency, CongressDaily reports (Edney, CongressDaily, 11/5). [click link for full article]

Milnacipran Demonstrated Significant Improvement In Pain And The Core Symptoms Of Fibromyalgia Syndrome, Data Show (Medical News Today)
Total daily dosages of milnacipran 100 mg and 200 mg demonstrated statistically significant and clinically meaningful improvements in both pain and other core symptoms associated with fibromyalgia syndrome (FMS), according to Phase III data presented this week at the 2007 American College of Rheumatology meeting in Boston, MA. [click link for full article]